FDA’s Office Of Regulatory Affairs Loses Chief, Policy Manager
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity
You may also be interested in...
Opening China Offices Brings FDA Early Test On Bridging Globalization Gaps
FDA's opening of offices in China will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments but also in restructuring itself to operate with worldwide footing
Opening China Offices Brings FDA Early Test On Bridging Globalization Gaps
FDA's opening of offices in China will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments but also in restructuring itself to operate with worldwide footing
Opening China Offices Brings FDA Early Test On Bridging Globalization Gaps
FDA's opening of offices in China will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments but also in restructuring itself to operate with worldwide footing